Perimenopause and menopause cause significant changes in the body. This course goes into the effects of these life transitions and how that may impact mental health.
Description:
The transition into perimenopause and menopause is widely misunderstood by patients and providers alike. This course will provide an explanation of menopause and how the transition into menopause impacts all aspects of a woman’s life with a focus on how it may show up in mental health practices.
Objectives
At the end of this course, participants should be able to:
Distinguish 3 symptoms related to menopause.
Integrate knowledge of the role of menopausal hormone changes on mental health into case conceptualization with clients.
Integrate knowledge of the role of menopausal hormone changes on quality of life into case conceptualization with clients.
Demonstrate knowledge of two evidence-based non-hormonal treatments for menopausal symptoms.
Execute understanding of two evidence-based benefits of estrogen treatment.
Demonstrate knowledge of two evidence-based supplements for the treatment of menopausal symptoms
Target Audience: Introductory level for clinicians. This training is not meant to take the place of medical advice or be medical advice. This training is for educational purposes only.
Date: Asynchronous, Self-Paced Home Study
Time: Asynchronous, Self-Paced Home Study
Cost: $75 USD
NBCC: 2 CEs
ACEP No. 7365
Gina Abbondante, LLC
ASWB: 2 CEs
ACE #1909
OCD Training School
APA: 2 CEs
Getting Your Certificate: You will need to complete both a course evaluation and a course quiz. Please set aside ample time to complete both in one sitting. A course evaluation link will be provided in your course materials. Once you submit your evaluation, a quiz link will show up on the next screen. You will then take the quiz and upon a passing score of 80%, your certificate will automatically be sent to the email address you provide. You will have three attempts to pass the quiz. Please double-check the email address that you provide on the quiz (as well as the correct spelling of your name). Please check your spam folder if you do not see your certificate in your inbox.
Refund/Cancellation Policy: . No refunds given on asynchronous, self-paced home study courses.
Accommodations: If you have a specific learning need, please email us at hello@ocdtrainingschool.com
About Your Trainer:
Colleen McCleery, MD, FACOG
Colleen McCleery, MD, FACOG, is the Medical Director of Renuva HRT & Wellness. Dr. McCleery is a board-certified OB/GYN specializing in perimenopause, menopause, and sexual dysfunction. She has been in practice for over 27 years and trained with Dr. Gino Tutera, an international pioneer in HRT therapy.
Early on, Dr. McCleery recognized the health benefits of relieving menopausal symptoms with bioidentical hormone replacement therapy (HRT). Dr. McCleery brings thousands of hours of HRT clinical experience to every patient and is an expert in the dosing and timing of HRT medications—providing a customized ‘hormone journey’ for every individual.
Dr. McCleery graduated from Robert Wood Johnson Medical School of NJ-New Brunswick and completed an Obstetrics/Gynecology residency at Thomas Jefferson University Hospital. She earned her bachelor’s in medical technology from Thomas Jefferson University and her master’s in molecular biology and immunology from Rutgers University-New Brunswick in New Jersey. She also studied at the University of Michigan, receiving a certificate in sexual health education and counseling.
She is a Menopause Society certified practitioner and a member of the European Andropause and Menopause Society and a member of the American Association of Sexual Educators, Counselors and Therapists (AASECT) and International Society for the Study of Women’s Sexual Health (ISSWSH). She is also a sexual counselor, certified by AASECT. Before becoming the Medical Director of Renuva, Dr. McCleery worked at Virtua Health.
NOTE: This training is for individual clinician use only. If you have a group practice, you will need to set up an account for each individual clinician. SHARING OF ACCOUNTS, TRAINING ACCESS, OR PASSWORDS WILL RESULT IN TERMINATION OF TRAINING ACCESS. NO REFUNDS WILL BE OFFERED. Email hello@OCDTrainingSchool.com if you have any questions.
Gina Abbondante LLC has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7365. Programs that do not qualify for NBCC credit are clearly identified. Gina Abbondante LLC is solely responsible for all aspects of the programs.
OCD Training School, #1909, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards have the final authority on courses accepted for continuing education credit. ACE provider approval period: 10/26/24-10/26/27.
OCD Training School is approved by the American Psychological Association to sponsor continuing education for psychologists. OCD Training School maintains responsibility for this program and its content.
OCD Training School is not responsible to verify that American Psychological Association, ASWB, or NBCC continuing education credits are approved by an attendee's respective state licensing Board.
Partial CE credit cannot be given. Live trainings must be attended in their entirety to receive credit. Partial credit cannot be given if an attendee joins late, leaves early, or is not present for the entirety of the live, virtual training.
There is no conflict of interest related to grant funding or research findings. There is no commercial support that would indicate a conflict of interest in regards to the program content, instructor, sponsor, or an endorsement of any other product.
You can reach us at hello@ocdtrainingschool.com
Bibliography:
Baik, S.H. et al (2024). Use of menopausal hormone therapy beyond age 65 years and its effects on women’s health outcomes by types, routes, and doses. Menopause. 31(5),363-371.
Bevry, M.L. (2024). Addressing menopause symptoms in the primary care setting: opportunity to bridge care delivery gaps. Menopause. Accepted July 2024,1-5.
CONSENSUS RECOMMENDATIONS Menopause and the workplace: consensus recommendations from The Menopause Society. Menopause. 31 (9),741-749.
Cyranowski, J.M. (2021). Practice Considerations for Behavioral Therapies for depression and anxiety in midlife women. NAMS Practice Pearl. October 2021: 1-4.
Editorial (2022). Attitudes towards menopause: time for change. Lancet. Vol 399. Pg 2243
Fenton, A. (2021). Weight, Shape, and Body Composition Changes at Menopause. Journal of Mid-life Health. Vol 12, 187-192.
Gennazzi, A.R. (2024) Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper. International of obstetrics and gynecology. 2024 Feb;164(2):516-530.
Grigolon, R.B. et al. (2023). Effects of nutritional interventions on the severity of depression and anxiety symptoms of women in the menopause transition and menopause: a systematic review, meta-analysis, and meta-regression. Menopause. January 2023. 30(1):95-107.
Haelle, T. (2024). Hormone Therapy for Menopause Remains at Historic Lows Despite Effectiveness and Safety Profile. Medscape. September 17, 2024.
Hooper, S. C. et al. (2023) Mental health and quality of life in post-menopausal women as a function of retrospective menopause symptom severity. Menopause. 29(6): 707–713
Hunter, M. S. (2020). Cognitive behavioral therapy for menopausal symptoms. Climacteric, 24(1), 51–56.
Koca, H.U. (2024). The effects of acupressure, laughter yoga, and a mindfulness-based stress reduction program applied to postmenopausal women for menopause symptoms and quality of life. Menopause. 31 (10): 879-886.
NAMS position statement (2022). Menopause: 29 (7): 767-794.
Nowakawski, S. (2021). Cognitive-Behavioral Therapy for sleep Disorders at Midlife. NAMS Practice Pearl. February 2021. 1-4
Rosendhal, J. (2024) Meta-analytic evidence on the efficacy of hypnosis for mental and somatic health issues: a 20-year perspective. Front. Psychol., 07 January 2024 Volume 14, pg. 1-20.
Shufelt, C.L. et al. (2023). The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. June, 2023. 30(6):573-590.
Stuenkel, C. A. (2024). What is Menopause? Menopause 31(9),837-838.
Wen, J. (2024). The psychological side of menopause: evidence from the comorbidity network of menopausal, anxiety, and depressive symptoms. Menopause 31(10),897-904.
APA Approved Sponsor
NBCC ACEP No. 7365
ASWB ACE #1909